PA
PJP icon

PFG Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

PFG Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,745
Closed -$220K – 692
2024
Q1 		$220K Buy
+2,745
New +$213K 0.02% 605

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PFG Advisors's PJP Position: Q2 2024 in Review

PFG Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2024, closing a stake of 2,745 shares — an estimated $220K sold.

PFG Advisors first reported a position in PJP in Q1 2024 and held it in 1 quarter. The position peaked at $220K in Q1 2024. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

  • PFG Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • PFG Advisors sold 2,745 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $220K.
  • PFG Advisors first reported a position in Invesco Pharmaceuticals ETF in Q1 2024 and held it in 1 quarter.
  • PFG Advisors's Invesco Pharmaceuticals ETF position peaked at $220K in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on PFG Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.